Call for Abstracts - Cancer Genomics in Africa

Submission deadline: 8 January 2021

The African Organisation for Research and Training in Cancer (AORTIC) invites abstracts for its Inaugural Cancer Genomics in Africa Conference. The conference will be convened under the theme “African Genomic Diversity: A Roadmap to Global Equity in Cancer Control”. The scientific programme will feature a wide range of sessions with experts, researchers, and up-and-coming leaders in Genomics of Cancer in Africans, on the Continent and in the African Diaspora.

This is an opportunity to share your research with African and international colleagues who are actively working in Cancer Genomics in Africa. Abstracts of both empirical and theoretical studies related to genetics or genomics of cancers are welcome, and researchers at all career stages are encouraged to submit one or more abstracts.

Abstracts will be peer reviewed. Acceptance will be based on content, available space, and overall programme balance. Abstracts should be relevant to Cancer Genomics in Africa. Abstracts must adequately describe the research performed to allow reviewers to evaluate the quality, originality, and thoroughness of the work. ABSTRACT SPECIFICATIONS • Abstracts may be submitted in English, French, or Portuguese. • Abstract title should be typed in UPPER CASE. The title should define the topic and contain no abbreviations. • In the body of the abstract, standard abbreviations need not be defined; other abbreviations and acronyms should be defined on first use. • Abstracts should contain four sections: 1. OBJECTIVE: introductory sentence indicating the objective and purpose of the study. 2. METHODS: description of experimental procedures, including applicable statistical evaluation. 3. RESULTS: summary of the data and results. 4. CONCLUSIONS: statement of the study’s conclusions. • Generic names for pharmaceuticals, biologicals, and medical devices should be used in place of trade names. Trade names should only be used if equivalent products from multiple manufacturers are being compared. • Overly commercial abstracts will not be accepted. • Do not include graphics, photographs, or tables. • Maximum word count for the body of the abstract is 300 words. • Submissions may have one presenting author and up to six co-authors. • The submitting author must be the presenting author. The submitting author’s details must be entered first. All correspondence from the Programme Secretariat will be sent to submitting

• The abstract will be listed under the submitting (presenting) author’s name in the conference programme and the electronic abstract publication.

• Abstracts must be submitted electronically via the Call for Abstract Submission site

• Authors of accepted abstracts will be invited to give an oral presentation or a poster presentation.

While the effort will be made to accommodate the author’s preference in presentation format, the final decision will rest with the Scientific Programme Committee.

For more information see the attachment:

Download • 1.84MB

1 view0 comments

Recent Posts

See All

MADCaP Network
Dana-Farber Cancer Institute
450 Brookline Avenue
Boston, MA 02215

Supported by Dana-Farber Cancer Institute

MADCaP is grant-funded by the National Cancer Institute

© Copyright 2016-2020 

Dana-Farber Cancer Institute.

Use of MADCaP is subject to our terms of use and our privacy policy.